Code for the mRECIST analysis used in 
Telarovic, I., Yong, C. S. M., Kurz, L., Vetrugno, I., Reichl, S., Sanchez Fernandez, A., Cheng, H. W., Winkler, R., Guckenberger, M., Kipar, A., Ludewig, B., Pruschy, M. Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease. (2024).
Telarovic, I., Yong, C. S. M., Guckenberger, M., Unkelbach, J. & Pruschy, M. Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model. Neoplasia. 31, 100812 (2022). https://doi.org/10.1016/j.neo.2022.100812

Adapted from
Gao, H. et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nature Medicine 21, 1318-1325 (2015). https://doi.org/10.1038/nm.3954
